Efficacy and Safety of Talampanel as Adjunctive Therapy in Patients With Partial Seizures: A Phase II Clinical Trial.

Trial Profile

Efficacy and Safety of Talampanel as Adjunctive Therapy in Patients With Partial Seizures: A Phase II Clinical Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Mar 2011

At a glance

  • Drugs Antiepileptic drugs; Talampanel
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Mar 2011 Actual initiation date (January 2002) added as reported by ClinicalTrials.gov.
    • 16 Mar 2011 Actual end date (January 2006) added as reported by ClinicalTrials.gov.
    • 06 May 2008 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 6 May 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top